Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2020

01-12-2020 | Study protocol

Scaling up Quality Improvement for Surgical Teams (QIST) – avoiding surgical site infection and anaemia at the time of surgery: protocol for a cluster randomised controlled trial

Authors: Ashley B Scrimshire, Alison Booth, Caroline Fairhurst, Mike Reed, Win Tadd, Annie Laverty, Belen Corbacho, David Torgerson, Catriona McDaid

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Measures shown to improve outcomes for patients often fail to be adopted into routine practice in the NHS. The Institute for Health Improvement Breakthrough Series Collaborative (BSC) model is designed to support implementation at scale. This trial aims to assess the effectiveness and cost-effectiveness of quality improvement collaboratives (QICs) based on the BSC method for introducing service improvements at scale in the NHS.

Methods

Forty Trusts will be randomised (1:1) to introduce one of two protocols already shown to improve outcomes in patients undergoing elective total hip and knee replacement surgery.
The intervention is improvement collaboratives based on the BSC model, a learning system that brings together a large number of teams to seek improvement focussed on a proven intervention. Collaboratives aim to deliver at scale, maximise local engagement and leadership and are designed to build capacity, enable learning and prepare for sustainability. Collaboratives involve Learning Sessions, Action Periods, and a summative congress.
Trusts will be supported to introduce either: decolonisation for Methicillin Sensitive Staphylococcus aureus (MSSA) to reduce post-operative infection (QIST: Infection), or an anaemia optimisation programme to reduce peri-operative blood transfusions (QIST: Anaemia). Trusts will continue with their usual practice for whichever protocol they are not introducing. Anonymised data related to both infection and anaemia outcomes for patients undergoing hip or knee arthroplasty at all sites will mean that the two groups act as controls for each other.
The primary outcome for the QIST: Infection collaborative is deep MSSA surgical site infection within 90 days of surgery, and for the QIST: Anaemia collaborative is blood transfusion within 7 days of surgery. Patient-level secondary outcomes include length of hospital stay and readmission, which will also inform the economic costings. Qualitative interviews will evaluate the support provided to teams.

Discussion

The scale of this trial brings considerable challenges and potential barriers to delivery. Anticipated challenges relate to recruiting and sustaining up to 40 organisations, each with its own culture and context. This complex project with multiple stakeholders across a large geographical area will be managed by experienced senior-level project leaders with a proven track record in advanced project management. The team should ensure effective project governance and communications.

Trial registration

ISRCTN, ISRCTN11085475. Prospectively registered on 15 February 2018.
Literature
1.
Shekelle PG, Pronovost PJ, Wachter RM, Taylor SL, Dy SM, Foy R, et al. Advancing the science of patient safety. Ann Intern Med. 2011;154(10):693–6.PubMedCrossRef
2.
de Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care. 2008;17(3):216–23.PubMedCrossRef
3.
Davidoff F. Heterogeneity is not always noise: lessons from improvement. JAMA. 2009;302(23):2580–6.PubMedCrossRef
4.
5.
Nadeem E, Olin SS, Hill LC, Hoagwood KE, Horwitz SM. Understanding the components of quality improvement collaboratives: a systematic literature review. Milbank Q. 2013;91(2):354–94.PubMedPubMedCentralCrossRef
6.
Wells S, Tamir O, Gray J, Naidoo D, Bekhit M, Goldmann D. Are quality improvement collaboratives effective? A systematic review. BMJ Qual Saf. 2018;27(3):226–240.CrossRef
7.
Ministry of Health. A review of the national orthopaedic Enhanced Recovery after Surgery (ERAS) quality improvement collaborative: November 2013–March 2015. Wellington: Ministry of Health; 2017.
8.
Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet (London, England). 2011;378(9800):1396–407.CrossRef
9.
Goodnough LT, Monk TG, Ozier Y, Slappendel R, Szpalski M, Maniatis A, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth. 2011;106(1):13–22.PubMedPubMedCentralCrossRef
10.
Kotzé A, Harris A, Baker C, Iqbal T, Lavies N, Richards T, et al. British Committee for Standards in Haematology guidelines on the identification and management of pre-operative anaemia. Br J Haematol. 2015;171(3):322–31.PubMedCrossRef
11.
Munoz M, Acheson AG, Auerbach M, Besser M, Habler O, Kehlet H, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017;72(2):233–47.PubMedCrossRef
12.
Meybohm P, Richards T, Isbister J, Hofmann A, Shander A, Goodnough LT, et al. Patient blood management bundles to facilitate implementation. Transfus Med Rev. 2017;31(1):62–71.PubMedCrossRef
13.
Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S, Shander A, Richards T, Pavía J, et al. ‘Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients†. Br J Anaesth. 2015;115(1):15–24.PubMedCrossRef
14.
Boralessa H, Goldhill DR, Tucker K, Mortimer AJ, Grant-Casey J. National comparative audit of blood use in elective primary unilateral total hip replacement surgery in the UK. Ann R Coll Surg Engl. 2009;91(7):599–605.PubMedPubMedCentralCrossRef
15.
Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57(6):1347–58.PubMedCrossRef
16.
17.
National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man. 15th annual report 2018: surgical data to 31 December 2017. 2018.
18.
Allepuz A, Serra-Sutton V, Martínez O, Tebé C, Nardi J, Portabella F, et al. Arthroplasty registers as post-marketing surveillance systems: The Catalan Arthroplasty Register. Rev Esp Cir Ortop Traumatol. 2013;57(1):27–37.PubMed
19.
Sochart DH. The infected implant - what next? Praha: Triton; 2012. p. 111.
20.
Zmistowski BPJ. A quarter of patients treated for PJI dead within 5 years. Thorofare: Orthopedics Today; 2013.
21.
Vanhegan IS, Malik AK, Jayakumar P, Ul Islam S, Haddad FS. A financial analysis of revision hip arthroplasty. J Bone Joint Surg Br. 2012;94-B(5):619.CrossRef
22.
Vanhegan IS, Morgan-Jones R, Barrett DS, Haddad FS. Developing a strategy to treat established infection in total knee replacement. J Bone Joint Surg Br. 2012;94-B(7):875.CrossRef
23.
Chen AF, Wessel CB, Rao N. Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clin Orthop Relat Res. 2013;471(7):2383–99.PubMedPubMedCentralCrossRef
24.
Schweizer M, Perencevich E, McDanel J, Carson J, Formanek M, Hafner J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ. 2013;346:f2743.PubMedPubMedCentralCrossRef
25.
World Health Organisation. Global guidelines for the prevention of surgical site infection; 2016. p. 1–186.
26.
Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466(7):1710–5.PubMedPubMedCentralCrossRef
27.
Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90(1):12–23.PubMedCrossRef
28.
Pujol-Nicolas A, Morrison R, Casson C, Khan S, Marriott A, Tiplady C, et al. Preoperative screening and intervention for mild anemia with low iron stores in elective hip and knee arthroplasty. Transfusion. 2017;57(12):3049–57.PubMedCrossRef
29.
Bhargava A, Salim M, Banavasi HV, Neelam V, Wenzel R, Sims KL, et al. Surgical site infections following Birmingham hip resurfacing. Infect Control Hosp Epidemiol. 2016;37(11):1383–6.PubMedCrossRef
30.
Borus T, Thornhill T. Unicompartmental knee arthroplasty. J Am Acad Orthop Surg. 2008;16(1):9–18.PubMedCrossRef
31.
32.
Marshall DA, Pykerman K, Werle J, Lorenzetti D, Wasylak T, Noseworthy T, et al. Hip resurfacing versus total hip arthroplasty: a systematic review comparing standardized outcomes. Clin Orthop Relat Res. 2014;472(7):2217–30.PubMedPubMedCentralCrossRef
33.
Torgerson DJ, Torgerson CJ. Designing randomised trials in health, education and the social sciences. London: Palgrave Macmillan; 2008.CrossRef
34.
35.
The National Joint Registry Editorial Board. 14th annual report national joint registry for England, Wales, Northern Ireland and the Isle of Man. 2017.
36.
Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9–17.PubMedCrossRef
37.
Jeans E, Holleyman R, Tate D, Reed M, Malviya A. Methicillin sensitive Staphylococcus aureus screening and decolonisation in elective hip and knee arthroplasty. J Infect. 2018;77(5):405–9.PubMedCrossRef
38.
39.
40.
West Midlands RTC Audit Group TC, Blest A, Lumley M, Hartley J, Baker C, Pailing M. Audit of blood use in orthopaedic surgery comparative report. Birmingham: West Midlands Regional Transfusion Committee; 2005. p. 1–15.
41.
Carling MS, Jeppsson A, Eriksson BI, Brisby H. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res. 2015;10:48.PubMedPubMedCentralCrossRef
42.
Monitor and NHS Trust Development Authority. Learning from mistakes league; 2016. p. 12.
43.
Saghaei M, Saghaei S. Implementation of an open-source customizable minimization program for allocation of patients to parallel groups in clinical trials. J Biomed Sci Eng. 2011;4:734–9.CrossRef
44.
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (Clinical research ed). 2014;348:g1687.
45.
Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25(12):986–92.PubMedCrossRef
46.
Public Health England. Protocol for the surveillance of surgical site infection. London: Public Health England; 2013. p. 82.
47.
Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 Statement: extension to cluster randomised trials. BMJ (Clinical research ed). 2012;345:e5661.
48.
Dixon-Woods M, McNicol S, Martin G. Ten challenges in improving quality in healthcare: lessons from the Health Foundation’s programme evaluations and relevant literature. BMJ Qual Saf. 2012;21(10):876.PubMedPubMedCentralCrossRef
Metadata
Title
Scaling up Quality Improvement for Surgical Teams (QIST) – avoiding surgical site infection and anaemia at the time of surgery: protocol for a cluster randomised controlled trial
Authors
Ashley B Scrimshire
Alison Booth
Caroline Fairhurst
Mike Reed
Win Tadd
Annie Laverty
Belen Corbacho
David Torgerson
Catriona McDaid
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-4152-3

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue

Study protocol

Feasibility and initial efficacy of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability: study protocol for a single-group, feasibility trial

Correction

Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study

Study protocol

DOuble SEquential External Defibrillation for Refractory Ventricular Fibrillation (DOSE VF): study protocol for a randomized controlled trial

Correction

Correction to: A nurse-led health coaching intervention for stroke survivors and their family caregivers in hospital to home transition care in Chongqing, China: a study protocol for a randomized controlled trial

Research

Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

Research

Using digital tools in the recruitment and retention in randomised controlled trials: survey of UK Clinical Trial Units and a qualitative study